Xin Dai

817 total citations · 1 hit paper
15 papers, 551 citations indexed

About

Xin Dai is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Xin Dai has authored 15 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Xin Dai's work include Gut microbiota and health (9 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diet and metabolism studies (4 papers). Xin Dai is often cited by papers focused on Gut microbiota and health (9 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diet and metabolism studies (4 papers). Xin Dai collaborates with scholars based in China, Thailand and Japan. Xin Dai's co-authors include Hailong Cao, Bangmao Wang, Tianyu Liu, Bangmao Wang, Huiqin Hou, Wanru Zhang, Sinan Wang, Yun Li, Danfeng Chen and Weilong Zhong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and Nutrients.

In The Last Decade

Xin Dai

14 papers receiving 546 citations

Hit Papers

Gut microbiota metabolite indole-3-acetic acid maintains ... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Dai China 12 354 150 135 83 65 15 551
Khairul Najmi Muhammad Nawawi Malaysia 10 350 1.0× 174 1.2× 181 1.3× 97 1.2× 53 0.8× 19 632
Youngcheon Song South Korea 12 428 1.2× 180 1.2× 94 0.7× 44 0.5× 48 0.7× 31 668
Bret Rust United States 10 347 1.0× 208 1.4× 73 0.5× 78 0.9× 123 1.9× 25 626
Angelika Pointner Austria 9 406 1.1× 226 1.5× 56 0.4× 64 0.8× 48 0.7× 14 627
Sang Hak Han South Korea 16 495 1.4× 183 1.2× 397 2.9× 67 0.8× 44 0.7× 35 932
Angelo Colucci Italy 11 264 0.7× 80 0.5× 120 0.9× 41 0.5× 36 0.6× 19 498
Mengci Li China 9 355 1.0× 181 1.2× 121 0.9× 113 1.4× 46 0.7× 15 555
Vania Cruz-Ramón Mexico 7 286 0.8× 129 0.9× 343 2.5× 106 1.3× 27 0.4× 10 723
Paulina Chinchilla-López Mexico 7 257 0.7× 107 0.7× 225 1.7× 108 1.3× 21 0.3× 14 606
Michelle Chan United States 12 213 0.6× 159 1.1× 154 1.1× 42 0.5× 47 0.7× 19 522

Countries citing papers authored by Xin Dai

Since Specialization
Citations

This map shows the geographic impact of Xin Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Dai more than expected).

Fields of papers citing papers by Xin Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Dai. The network helps show where Xin Dai may publish in the future.

Co-authorship network of co-authors of Xin Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Dai. A scholar is included among the top collaborators of Xin Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Dai. Xin Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Guo, Qianqian, Xin Dai, Stella Victorelli, et al.. (2025). Glycogen Synthase Kinase 3 β Hepatocyte Deletion Attenuates Ferroptosis and Metabolic Dysfunction-associated Steatohepatitis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 20(1). 101633–101633.
2.
Ye, Yulin, Limin Liu, Jing Yang, et al.. (2024). Ferroptosis: A therapeutic opportunity of inflammatory bowel disease. Chinese Medical Journal. 137(7). 874–876. 3 indexed citations
3.
Li, Mengfan, Yiyun Ding, Yue Dong, et al.. (2024). Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Gut Microbes. 16(1). 2377576–2377576. 45 indexed citations breakdown →
4.
Guo, Qin, Yun Li, Xin Dai, et al.. (2023). Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD). Nutrients. 15(17). 3722–3722. 26 indexed citations
5.
Niu, Miaomiao, et al.. (2022). 16S rRNA gene sequencing analysis of gut microbiome in a mini‐pig diabetes model. SHILAP Revista de lepidopterología. 5(1). 81–88. 11 indexed citations
6.
Dai, Xin, Rui Zhang, & Bangmao Wang. (2022). Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD. BMC Gastroenterology. 22(1). 55–55. 15 indexed citations
7.
Tang, Qiang, Chen Wang, Ge Jin, et al.. (2022). Early life dietary emulsifier exposure predisposes the offspring to obesity through gut microbiota-FXR axis. Food Research International. 162(Pt A). 111921–111921. 11 indexed citations
8.
Sun, Siyuan, Ling Liang, Qijin He, et al.. (2021). Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice. Frontiers in Nutrition. 8. 756565–756565. 33 indexed citations
9.
Li, Yun, Huiqin Hou, Xin Dai, et al.. (2021). Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling. Frontiers in Pharmacology. 12. 796590–796590. 23 indexed citations
10.
Hou, Huiqin, Danfeng Chen, Kexin Zhang, et al.. (2021). Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?. Cancer Letters. 526. 225–235. 161 indexed citations
11.
Dai, Xin, et al.. (2021). The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database. BMC Cancer. 21(1). 1057–1057. 23 indexed citations
12.
Dai, Xin, Chen Wang, Zixuan Guo, et al.. (2021). Maternal sucralose exposure induces Paneth cell defects and exacerbates gut dysbiosis of progeny mice. Food & Function. 12(24). 12634–12646. 11 indexed citations
13.
Dai, Xin, Huiqin Hou, Wanru Zhang, et al.. (2020). Microbial Metabolites: Critical Regulators in NAFLD. Frontiers in Microbiology. 11. 567654–567654. 78 indexed citations
14.
Dai, Xin, Zixuan Guo, Danfeng Chen, et al.. (2020). Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. Gut Microbes. 11(4). 1043–1063. 65 indexed citations
15.
Dai, Xin & Bangmao Wang. (2015). Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice. 2015. 1–6. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026